Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome.

La Manna G, Corsini S, Iannelli S, Cappuccilli ML, Comai G, Iorio M, Todeschini P, Carretta E, Scolari MP, Bontadini A, Stefoni S.

Ann Transplant. 2013 Nov 13;18:611-21. doi: 10.12659/AOT.889157.

2.

KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.

Littera R, Piredda G, Argiolas D, Lai S, Congeddu E, Ragatzu P, Melis M, Carta E, Michittu MB, Valentini D, Cappai L, Porcella R, Alba F, Serra M, Loi V, Maddi R, Orrù S, La Nasa G, Caocci G, Cusano R, Arras M, Frongia M, Pani A, Carcassi C.

PLoS One. 2017 Jul 7;12(7):e0180831. doi: 10.1371/journal.pone.0180831. eCollection 2017.

3.

Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.

Vampa ML, Norman PJ, Burnapp L, Vaughan RW, Sacks SH, Wong W.

Transplantation. 2003 Oct 27;76(8):1220-8.

PMID:
14578757
4.

KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation.

Hanvesakul R, Kubal C, Moore J, Neil D, Cook M, Ball S, Briggs D, Moss P, Cockwell P.

PLoS One. 2011;6(8):e23631. doi: 10.1371/journal.pone.0023631. Epub 2011 Aug 31.

5.

[Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].

Bao XJ, He J, Chen ZX, Wu DP, Yao L, Yuan XN, Cen JN, Qiu QC, Di WY, Zhang H, Zhang J, Zhou XH, Xu HX.

Zhonghua Xue Ye Xue Za Zhi. 2007 Aug;28(8):510-3. Chinese.

PMID:
18078124
6.

KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.

Legaz I, López-Álvarez MR, Campillo JA, Moya-Quiles MR, Bolarín JM, de la Peña J, Salgado G, Gimeno L, García-Alonso AM, Muro M, Miras M, Alonso C, Álvarez-López MR, Minguela A.

Transplantation. 2013 Apr 27;95(8):1037-44. doi: 10.1097/TP.0b013e318286486c.

PMID:
23478359
7.
8.

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.

Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.

9.

Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.

Moroso V, van der Meer A, Tilanus HW, Kazemier G, van der Laan LJ, Metselaar HJ, Joosten I, Kwekkeboom J.

Transpl Int. 2011 Sep;24(9):932-42. doi: 10.1111/j.1432-2277.2011.01286.x. Epub 2011 Jun 14.

10.

[Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation].

Liang ZY, Ren HY, Cen XN, Qiu ZX, Wang LH, Ou JP, Li Y, Wang MJ, Wang WS, Xu WL, Dong YJ, Yin Y, Sun YH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Feb;21(1):155-60. doi: 10.7534/j.issn.1009-2137.2013.01.032. Chinese.

PMID:
23484711
11.

Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.

Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P.

Blood. 2003 May 1;101(9):3730-40. Epub 2003 Jan 2.

12.

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

Wang H, Zhai WJ, Wang HH, He Y, Zhou Z, Zhao YX, Zhai WH, Zhang RL, Wang M, Feng SZ, Han MZ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Oct;31(5):533-7. Chinese.

13.

Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.

Lee H, Park KH, Park HS, Ryu JH, Lim J, Kim Y, Na GH, Kim DG, Oh EJ.

Ann Lab Med. 2017 Jan;37(1):45-52. doi: 10.3343/alm.2017.37.1.45.

14.

KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.

Michelo CM, van der Meer A, Tijssen HJ, Zomer R, Stelma F, Hilbrands LB, Joosten I.

Transplantation. 2015 Jul;99(7):1506-13. doi: 10.1097/TP.0000000000000497.

PMID:
25427165
15.
16.

NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.

Björklund AT, Schaffer M, Fauriat C, Ringdén O, Remberger M, Hammarstedt C, Barrett AJ, Ljungman P, Ljunggren HG, Malmberg KJ.

Blood. 2010 Apr 1;115(13):2686-94. doi: 10.1182/blood-2009-07-229740. Epub 2010 Jan 22.

17.

Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation.

Nowak I, Magott-Procelewska M, Kowal A, Miazga M, Wagner M, Niepiekło-Miniewska W, Kamińska M, Wiśniewski A, Majorczyk E, Klinger M, Łuszczek W, Pawlik A, Płoski R, Barcz E, Senitzer D, Kuśnierczyk P.

PLoS One. 2012;7(9):e44718. doi: 10.1371/journal.pone.0044718. Epub 2012 Sep 13.

18.
19.

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.

Sekine T, Marin D, Cao K, Li L, Mehta P, Shaim H, Sobieski C, Jones R, Oran B, Hosing C, Rondon G, Alsuliman A, Paust S, Andersson B, Popat U, Kebriaei P, Muftuoglu M, Basar R, Kondo K, Nieto Y, Shah N, Olson A, Alousi A, Liu E, Sarvaria A, Parmar S, Armstrong-James D, Imahashi N, Molldrem J, Champlin R, Shpall EJ, Rezvani K.

Blood. 2016 Jul 14;128(2):297-312. doi: 10.1182/blood-2016-03-706317. Epub 2016 May 31.

20.

Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival.

Tran TH, Middleton D, Döhler B, Scherer S, Meenagh A, Sleator C, Opelz G.

Am J Transplant. 2009 Jul;9(7):1674-8. doi: 10.1111/j.1600-6143.2009.02609.x. Epub 2009 Apr 10.

Supplemental Content

Support Center